Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

BBH vs HTEC overlap: 24% of top holdings shared

Bottom line

How much do BBH and HTEC overlap?

24% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 31.7% of BBH's assets and 13.8% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.

HTEC holds far more positions (63 vs 25), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

BBHHTEC
Weight overlap (top 25)24%
Shared holdings7
Weight in shared holdings31.7%13.8%
Total positions2563
Expense ratio0.35%0.68%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings BBH and HTEC have in common

Holding% of BBH% of HTECOverlap
Vertex Pharmaceuticals Inc9.10%1.91%1.91%
Regeneron Pharmaceuticals Inc6.21%1.97%1.97%
Natera Inc4.92%2.23%2.23%
IQVIA Holdings Inc4.31%2.10%2.10%
Illumina Inc3.17%2.09%2.09%
Incyte Corp2.49%1.80%1.80%
Charles River Laboratories International Inc1.50%1.71%1.50%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in BBH

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Revolution Medicines Inc — 5.27%
  4. Argenx SE — 4.97%
  5. Alnylam Pharmaceuticals Inc — 3.83%
  6. Biogen Inc — 3.63%
  7. Moderna Inc — 3.36%
  8. United Therapeutics Corp — 2.83%
  9. BeOne Medicines Ltd — 2.81%
  10. Insmed Inc — 2.67%
  11. Neurocrine Biosciences Inc — 2.08%
  12. BioNTech SE — 1.94%
  13. Icon Plc — 1.90%
  14. Bio-Techne Corp — 1.54%
  15. BioMarin Pharmaceutical Inc — 1.34%

Only in HTEC

  1. Caredx, Inc. — 2.68%
  2. Guardant Health, Inc. — 2.31%
  3. Twist Bioscience Corp — 2.23%
  4. Thermo Fisher Scientific Incorporated — 2.18%
  5. Medpace Holdings, Inc. — 2.12%
  6. Adaptive Biotechnologies Corporation — 2.11%
  7. Arrowhead Pharmaceuticals, Inc. — 2.08%
  8. Glaukos Corporation — 1.92%
  9. Stryker Corporation — 1.91%
  10. Livanova Plc — 1.87%
  11. Siemens Healthineers AG — 1.85%
  12. Lonza Group AG — 1.85%
  13. Abbott Laboratories — 1.79%
  14. AxoGen, Inc. — 1.77%
  15. Boston Scientific Corporation — 1.73%

Asset mix

Asset typeBBHHTEC
Stocks100.0%99.8%
Cash & short-term funds0.1%0.2%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryBBHHTEC
US87.3%82.9%
NL6.0%1.6%
CH2.8%5.0%
HK—3.7%
DE1.9%1.9%
IE1.9%—
FR—1.6%
IT—1.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do BBH and HTEC overlap?
About 24% by weight. 7 securities appear in both funds' top 25 holdings; they make up 31.7% of BBH's assets and 13.8% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do BBH and HTEC have in common?
The largest shared holdings are Natera Inc, IQVIA Holdings Inc, Illumina Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc.
Should I own both BBH and HTEC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, BBH or HTEC?
HTEC is broader, with 63 positions versus 25 for BBH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.